The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence

İDİLMAN, RAMAZAN; Akyildiz, Murat; Keskin, Onur; Gungor, Gokhan; Yilmaz, Tonguc; Kalkan, Cagdas; Dayangac, Murat; ÇINAR, KUBİLAY; BALCI, DENİZ; Hazinedaroglu, SELÇUK; Tokat, Yaman

doi:10.1111/ctr.12804

The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence

Atıf İçin Kopyala

İDİLMAN R., Akyildiz M., Keskin O., Gungor G., Yilmaz T. U., Kalkan C., ...Daha Fazla

CLINICAL TRANSPLANTATION, cilt.30, sa.10, ss.1216-1221, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 30 Sayı: 10
Basım Tarihi: 2016
Doi Numarası: 10.1111/ctr.12804
Dergi Adı: CLINICAL TRANSPLANTATION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1216-1221
Anahtar Kelimeler: entecavir, hepatitis B immunoglobulin, liver transplantation, tenofovir disoproxil fumarate, LIVER-TRANSPLANT RECIPIENTS, HEPATOCELLULAR-CARCINOMA, SURFACE-ANTIGEN, RISK-FACTORS, PROPHYLAXIS, PREVENTION, IMMUNOPROPHYLAXIS, REINFECTION, LAMIVUDINE, INFECTION
Ankara Üniversitesi Adresli: Evet

Özet

BackgroundThe aim of this study was to determine the long-term efficacy of nucleos(t)ide analog (NA) and low-dose hepatitis B immunoglobulin (HBIG) combination treatment for preventing post-transplant hepatitis B virus (HBV) recurrence.